Hampshire pig Nemo gets pioneering cancer treatment

July 18, 2013
Hampshire pig Nemo gets pioneering chemo
Nemo, a Hampshire pig living at the Cornell University Hospital for Animals, is believed to be the first pig to be treated for lymphoma.

Playful as a puppy even at 730 pounds, Nemo, a rescued black-and-white Hampshire pig, became a porcine pioneer when lymphoma struck.

Undergoing a novel care plan, he became a teaching case for veterinary oncologists at the Cornell University Hospital for Animals (CUHA), paving the way to combat cancer in large animals.

Nemo is believed to be the first pig to be treated for lymphoma. The pig's medical treatment began when his owner, George Goldner, saw his friend fall ill.

"I want to do everything humanly possible for my animals," said Goldner, who has a farm sanctuary in New York's Catskill Mountains. "They're rescues, and we [with co-owner Nancy Krieg] keep them for life. Pigs are very smart. If you're nice to them they're very friendly. Nemo's a real performer; he's attractive, loves people and has a great personality."

When the 4-year-old had a coughing fit and laid down in the snow, Goldner drove Nemo nearly four hours to Cornell's hospital, where the pig was diagnosed with presumptive B-cell lymphoma, a .

CUHA clinicians from across fields worked to prepare for intravenous medication delivery. In the first such procedure ever done to treat a sick pig, surgeon Jim Flanders, who had performed similar procedures in smaller animals, joined large-animal surgeon Susan Fubini to surgically implant a vascular access port.

They ran a catheter up a vein in Nemo's neck to a port behind his ear, creating a route for delivering drugs where they would be most effective while minimizing harm. Resident Emily Barrell selected and delivered the .

"Although lymphoma has been documented in swine, there aren't any documented cases of pigs being treated for it," said CUHA Cheryl Balkman. "We adapted a treatment plan based on what we know is effective in dogs, cats and humans with lymphoma."

Nemo's clinical signs soon resolved, and he has continued to do well during long-term treatment. Though little is known about the prognosis for pigs with cancer, Nemo has the notable distinction of establishing a precedent for pigs battling cancer, giving veterinarians valuable information for helping large animals. Since arriving in March, Nemo has resided at CUHA.

"He has a better life there," said Goldner. "He's running around digging holes, eating pineapples, communicating vocally and getting lots of love. CUHA's people play with him and bring him treats, and he plays funny tricks like tossing water at the residents. The vets have cared for him with amazing dedication and thoughtfulness, especially Dr. Barrell. It's been a wonderful effort on the part of several people: a testament to the outstanding work done at Cornell."

Explore further: Human and canine lymphomas share molecular similarities, first large-scale comparison shows

Related Stories

Human and canine lymphomas share molecular similarities, first large-scale comparison shows

June 25, 2013
Humans and their pet dogs are close, so close that they both develop a type of cancer called diffuse large B-cell lymphoma. In humans it's the most common lymphoma subtype while in dogs, it's one of the most common cancers ...

Healthy-looking pigs at state fair found to have swine flu

August 17, 2012
(HealthDay) -- They were being shown off as healthy porcine specimens, but several of the show pigs at the Minnesota State Fair in 2009 actually were infected with swine flu, according to a new study.

MRSA thrives even without antibiotics

November 7, 2011
The MRSA bacterium, which is resistant to antibiotics, has spread rapidly in the past few years on pig farms. Extensive use of antibiotics is thought to help it spread, but reducing the use of antibiotics is not enough to ...

Pets battling cancer can join clinical trials too

June 14, 2013
(HealthDay)—If you hear that a friend's beloved family member has joined a clinical trial for cancer treatment, don't assume the patient is human.

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.